AzTrials
AzTrials

Postoperative Cognitive ImpairmentNCT06764745

Effect of Different Ventilation Modes on POCD in Elderly Patients with Abdominal Wall Hernia

A study testing PC Ventilation Modes, VC Ventilation Modes and PRVC Ventilation Modes in people with Postoperative Cognitive Impairment and Optic Nerve Sheath Edema, run by Inner Mongolia University of Science and Technology at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this clinical trial is to understand the effect of different ventilation patterns during surgery on postoperative cognitive impairment in elderly patients with abdominal wall hernias. It will also explore how to reduce the incidence of postoperative cognitive impairment. Read more about this study

Who is it for?
Ages 65 to 90 yearsHealthy volunteers can take part
What is being tested?
PC Ventilation Modes, VC Ventilation Modes and PRVC Ventilation Modes
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
471 participants
Where
1 siteChina
Study dates
1 Mar 2024to 28 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Age: 65-90 years
  • patients with abdominal wall hernias
  • American Society of Anesthesiologists general status (ASA-PS) classes II and III.

Who cannot join

  • Emergency (rather than elective) surgery or other types of surgery required
  • More than one surgery required during hospitalization
  • Preoperative demonstrated inability to communicate (due to coma, severe dementia, Parkinson's disease, severe hearing or visual impairment, or speech impairment).

Trial locations and contacts

1 site in 1 country.

China1 site
  • Inner Mongolia Baosteel Hospital

    Baotou, Inner Mongolia, 014010

Other trials in China

About this study

Official title: Effect of Different Ventilation Modes on POCD in Elderly Patients with Abdominal Wall Hernia: a Randomized Controlled Trial

The purpose of this clinical trial is to understand the effect of different ventilation patterns during surgery on postoperative cognitive impairment in elderly patients with abdominal wall hernias. It will also explore how to reduce the incidence of postoperative cognitive impairment. The main questions it aims to answer are:

  • Does the mode of ventilation affect the incidence of postoperative cognitive impairment in elderly patients?
  • Does optic nerve sheath edema affect the incidence of postoperative cognitive impairment in elderly patients? Researchers will monitor patients with different ventilation patterns intraoperatively and investigate postoperatively to see if the ventilation pattern affects postoperative cognitive impairment.
Read more

Participants will:

  • Randomly assigned to groups with different ventilation patterns
  • Record various values during surgery by the researchers
  • Presence of cognitive impairment assessed by cognitive scales after surgery
Being tested
PC Ventilation Modes, VC Ventilation Modes, PRVC Ventilation Modes
Keywords
Ventilation patterns, Elderly patients, Abdominal wall hernia, Postoperative cognitive impairment
Medical subject headings
Hernia, Abdominal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PC Ventilation ModesDevice

    Following induction, Group I patients received mechanical ventilation using the PC mode. The anesthetic machine (MAQUET Flow-I, Italy) parameters were set as follows: The inspiratory pressure (Pins) was adjusted to maintain an end-tidal carbon dioxide concentration (ETCO2) of 4.0-5.0 kPa. Pure oxygen and air were utilized at 0.3 L/min each, with an oxygen content of 41%. The positive end-expiratory pressure (PEEP) was set at 10 cmH2O, with an inspiration-to-expiration ratio of 1:2, a respiratory rate of 16 breaths per minute, and an oxygen content of 41%.

  • VC Ventilation ModesDevice

    Following induction, Group II patients received mechanical ventilation using the VC mode. The anesthetic machine (MAQUET Flow-I, Italy) parameters were set as follows: The inspiratory pressure (Pins) was adjusted to maintain an end-tidal carbon dioxide concentration (ETCO2) of 4.0-5.0 kPa. Pure oxygen and air were utilized at 0.3 L/min each, with an oxygen content of 41%. The positive end-expiratory pressure (PEEP) was set at 10 cmH2O, with an inspiration-to-expiration ratio of 1:2, a respiratory rate of 16 breaths per minute, and an oxygen content of 41%.

  • PRVC Ventilation ModesDevice

    Following induction, Group III patients received mechanical ventilation using the PRVC mode. The anesthetic machine (MAQUET Flow-I, Italy) parameters were set as follows: The inspiratory pressure (Pins) was adjusted to maintain an end-tidal carbon dioxide concentration (ETCO2) of 4.0-5.0 kPa. Pure oxygen and air were utilized at 0.3 L/min each, with an oxygen content of 41%. The positive end-expiratory pressure (PEEP) was set at 10 cmH2O, with an inspiration-to-expiration ratio of 1:2, a respiratory rate of 16 breaths per minute, and an oxygen content of 41%.

Study groups in NCT06764745
Study groupRoleWhat they receive
PC Ventilation patterns GroupExperimentalVentilation Modes Following induction, Group I patients received mechanical ventilation using the PC mode.
Receives: Device: PC Ventilation Modes
VC Ventilation patterns GroupExperimentalVentilation Modes Following induction, Group II patients received mechanical ventilation using the VC mode.
Receives: Device: VC Ventilation Modes
PRVC Ventilation patterns GroupExperimentalVentilation Modes Following induction, Group III patients received mechanical ventilation using the PRVC mode.
Receives: Device: PRVC Ventilation Modes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MMSE scale

    Range Score <21 Increased odds of dementia Score >25 Decreased odds of dementia Education Score < 21 Abnormal for 8" grade Score <23 Abnormal for high school education Score <24 Abnormal for college education Severity 24-30 No cognitive impairment 18-23 Mild cognitive impairment 0-17 Severe cognitive impairment

    Measured: From enrollment to two weeks after surgical treatment

  2. optic nerve sheath diameter (ONSD)

    The ONSD was assessed using ocular ultrasonography to non-invasively capture ICP. Bedside ultrasound measurements of the ONSD were performed by an experienced and professionally qualified ultrasound physician. Patients were positioned supine with their eyes softly closed, and their eyes were protected with disposable transparent patches. A 7.5 MHz linear probe (Micromaxx Ultrasound System; SonoSite Inc., Bothell, WA, USA) was gently placed on the closed upper eyelid without applying pressure to the eyeball, and sufficient ultrasound gel was applied to ensure clear imaging. The optic nerve sheath was checked and measured 3 mm beyond the globe, and three ONSD measures were performed, with the average value utilized as the final ONSD measurement, which was accurate to 0.01 mm.

    Measured: From induction of anesthesia to the end of surgery

  3. average airway pressure( PAWM)

    Mean airway pressure affects the patient's alveolar oxygenation status and blood circulation. Mean airway pressure is most affected by positive end-expiratory pressure, followed by prolongation of inspiratory time, which can also increase mean airway pressure.

    Measured: From induction of anesthesia to the end of surgery

  4. esophagealp ressure(PES)

    Esophageal pressure monitoring is a minimally invasive and clinically available method for estimating transpulmonary pressure, of which absolute values and changes are considered one of the main determinants of lung injury due to mechanical forces applied during mechanical ventilation . PES was monitored using a floating catheter (Swan-Ganz, USA) placed into the esophagus and coupled to a monitor (M8003A, Germany).

    Measured: From induction of anesthesia to the end of surgery

  5. PaCO2(mmHg)

    Arterial reference value: 35-45 mmHg, exceeding or falling below the reference value is called hyper- or hypocapnia. Exceeding 55mmHg may inhibit the respiratory center. It is the main index to determine the acid-base poisoning of each type.

    Measured: From induction of anesthesia to the end of surgery

  6. mean arterial pressure(MAP)

    Above 60 mmHg is sufficient to provide organ sustenance in the general population.calculated as MAP = diastolic pressure + 1/3 pulse pressure difference.

    Measured: From induction of anesthesia to the end of surgery

  7. heart rate(HR)

    Normal values for heart rate are 60-100 beats per minute.

    Measured: From induction of anesthesia to the end of surgery

Secondary outcomes (5)
  1. Aβ1-40 (pg·mL-1)

    In the morning, 10 mL of venous blood from the upper limbs was withdrawn under fasting conditions, put into polypropylene EDTA anticoagulation tubes, centrifuged at 1 000 r/min for 3 min within 60 min (maximal centrifugal force: 27 700×g), and plasma was extracted, frozen in a refrigerator at -20 ℃, and then left to be measured. Plasma Aβ1-40 and inflammatory indexes were detected by enzyme-linked immunosorbent assay in the two groups.

    Measured: From induction of anesthesia to the end of surgery

  2. S100 (pg·mL-1)

    In the morning, 10 mL of venous blood from the upper limbs was withdrawn under fasting conditions, put into polypropylene EDTA anticoagulation tubes, centrifuged at 1 000 r/min for 3 min within 60 min (maximal centrifugal force: 27 700×g), and plasma was extracted, frozen in a refrigerator at -20 ℃, and then left to be measured. Plasma Aβ1-40 and inflammatory indexes were detected by enzyme-linked immunosorbent assay in the two groups.

    Measured: From induction of anesthesia to the end of surgery

  3. IL-1β (pg·mL-1)

    In the morning, 10 mL of venous blood from the upper limbs was withdrawn under fasting conditions, put into polypropylene EDTA anticoagulation tubes, centrifuged at 1 000 r/min for 3 min within 60 min (maximal centrifugal force: 27 700×g), and plasma was extracted, frozen in a refrigerator at -20 ℃, and then left to be measured. Plasma Aβ1-40 and inflammatory indexes were detected by enzyme-linked immunosorbent assay in the two groups.

    Measured: From induction of anesthesia to the end of surgery

  4. IL-6 (pg·mL-1)

    In the morning, 10 mL of venous blood from the upper limbs was withdrawn under fasting conditions, put into polypropylene EDTA anticoagulation tubes, centrifuged at 1 000 r/min for 3 min within 60 min (maximal centrifugal force: 27 700×g), and plasma was extracted, frozen in a refrigerator at -20 ℃, and then left to be measured. Plasma Aβ1-40 and inflammatory indexes were detected by enzyme-linked immunosorbent assay in the two groups.

    Measured: From induction of anesthesia to the end of surgery

  5. TNF-α (pg·mL-1)

    In the morning, 10 mL of venous blood from the upper limbs was withdrawn under fasting conditions, put into polypropylene EDTA anticoagulation tubes, centrifuged at 1 000 r/min for 3 min within 60 min (maximal centrifugal force: 27 700×g), and plasma was extracted, frozen in a refrigerator at -20 ℃, and then left to be measured. Plasma Aβ1-40 and inflammatory indexes were detected by enzyme-linked immunosorbent assay in the two groups.

    Measured: From induction of anesthesia to the end of surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2025
  2. Study start1 Mar 2024
  3. Primary completion28 Feb 2025
  4. Study completion28 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
471 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06764745
Sponsor's protocol ID
MER-076
Status last verified
Oct 2024
First submitted
2 Jan 2025
Last updated
5 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing PC Ventilation Modes, VC Ventilation Modes and PRVC Ventilation Modes in people with Postoperative Cognitive Impairment and Optic Nerve Sheath Edema, run by Inner Mongolia University of Science and Technology at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MMSE scale (time frame: From enrollment to two weeks after surgical treatment). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in